Published in J Biol Chem on April 08, 1994
Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science (2004) 7.63
Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci U S A (2001) 3.28
TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci U S A (2001) 3.06
Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol (2009) 2.99
Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation. Proc Natl Acad Sci U S A (1999) 2.44
Mechanisms of cellular uptake of cell-penetrating peptides. J Biophys (2011) 2.34
Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways. J Clin Invest (2006) 2.15
The transcription factor Engrailed-2 guides retinal axons. Nature (2005) 2.11
Cell-penetrating peptide derived from human eosinophil cationic protein inhibits mite allergen Der p 2 induced inflammasome activation. PLoS One (2015) 1.99
Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment. AAPS J (2009) 1.99
Cell-penetrating peptides and antimicrobial peptides: how different are they? Biochem J (2006) 1.92
The design of guanidinium-rich transporters and their internalization mechanisms. Adv Drug Deliv Rev (2007) 1.91
The NH2-terminal peptide of alpha-smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo. J Cell Biol (2002) 1.82
Reduced infiltration and increased apoptosis of leukocytes at sites of inflammation by systemic administration of a membrane-permeable IkappaBalpha repressor. Arthritis Rheum (2004) 1.79
Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. Eur J Pharm Biopharm (2008) 1.78
Alpha-smooth muscle actin is crucial for focal adhesion maturation in myofibroblasts. Mol Biol Cell (2003) 1.70
Internalization of flax rust avirulence proteins into flax and tobacco cells can occur in the absence of the pathogen. Plant Cell (2010) 1.70
A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells. Mol Ther (2008) 1.58
Identification and characterization of receptor-specific peptides for siRNA delivery. ACS Nano (2012) 1.58
Peptide-guided gene delivery. AAPS J (2007) 1.57
Emerging targets and novel approaches to Ebola virus prophylaxis and treatment. BioDrugs (2013) 1.57
Myofibroblast development is characterized by specific cell-cell adherens junctions. Mol Biol Cell (2004) 1.56
Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery. Mol Membr Biol (2010) 1.51
Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. Prog Polym Sci (2007) 1.41
Disruption of the Rb--Raf-1 interaction inhibits tumor growth and angiogenesis. Mol Cell Biol (2004) 1.40
Translocation and endocytosis for cell-penetrating peptide internalization. J Biol Chem (2009) 1.36
Self-assembled quantum dot-peptide bioconjugates for selective intracellular delivery. Bioconjug Chem (2006) 1.34
Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. Adv Drug Deliv Rev (2007) 1.34
Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges. Pharmaceuticals (Basel) (2012) 1.32
Cell penetrating peptides: overview and applications to the delivery of oligonucleotides. Cell Mol Life Sci (2009) 1.31
Protein transduction from retroviral Gag precursors. Proc Natl Acad Sci U S A (2010) 1.30
Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis. Proc Natl Acad Sci U S A (2006) 1.28
Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro. J Cell Biol (1995) 1.28
Charge-dependent translocation of the Trojan peptide penetratin across lipid membranes. Biophys J (2003) 1.28
The many ways to cross the plasma membrane. Proc Natl Acad Sci U S A (2001) 1.26
Gold nanoparticles delivery in mammalian live cells: a critical review. Nano Rev (2010) 1.25
Cell-penetrating peptide-mediated delivery of TALEN proteins via bioconjugation for genome engineering. PLoS One (2014) 1.24
Cardioprotection from ischemia by a brief exposure to physiological levels of ethanol: role of epsilon protein kinase C. Proc Natl Acad Sci U S A (1999) 1.23
Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea. Mol Ther (2007) 1.22
SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D. Mol Cell Biol (2000) 1.21
Inhibition of Siah ubiquitin ligase function. Oncogene (2008) 1.20
Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study. Biochem J (2007) 1.20
The nonreceptor tyrosine kinase fer mediates cross-talk between N-cadherin and beta1-integrins. J Cell Biol (2000) 1.19
Modular utilization of distal cis-regulatory elements controls Ifng gene expression in T cells activated by distinct stimuli. Immunity (2010) 1.17
pHLIP-mediated translocation of membrane-impermeable molecules into cells. Chem Biol (2009) 1.16
Roles of arginine and lysine residues in the translocation of a cell-penetrating peptide from (13)C, (31)P, and (19)F solid-state NMR. Biochemistry (2009) 1.15
Alternative mechanisms for the interaction of the cell-penetrating peptides penetratin and the TAT peptide with lipid bilayers. Biophys J (2009) 1.14
Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery. Mol Ther (2012) 1.13
STAT3-stathmin interactions control microtubule dynamics in migrating T-cells. J Biol Chem (2009) 1.13
Structure and dynamics of cationic membrane peptides and proteins: insights from solid-state NMR. Protein Sci (2011) 1.13
Antimicrobial peptides with cell-penetrating peptide properties and vice versa. Eur Biophys J (2011) 1.12
Development of mitochondrial gene replacement therapy. J Bioenerg Biomembr (2004) 1.12
Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides. J Biol Chem (2011) 1.12
Identification of Grb2 as a novel binding partner of tumor necrosis factor (TNF) receptor I. J Exp Med (1999) 1.11
Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates. J Control Release (2011) 1.09
Membrane-bound dynamic structure of an arginine-rich cell-penetrating peptide, the protein transduction domain of HIV TAT, from solid-state NMR. Biochemistry (2010) 1.09
Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy. Hum Mol Genet (2013) 1.09
Modified FGF4 signal peptide inhibits entry of herpes simplex virus type 1. J Virol (2001) 1.08
Design of a bioactive cell-penetrating peptide: when a transduction domain does more than transduce. J Pept Sci (2009) 1.08
Non-metabolic membrane tubulation and permeability induced by bioactive peptides. PLoS One (2007) 1.07
PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47 phox. Proc Natl Acad Sci U S A (1996) 1.07
Biological applications of protein transduction technology. Trends Biotechnol (2003) 1.07
Transduction of the scorpion toxin maurocalcine into cells. Evidence that the toxin crosses the plasma membrane. J Biol Chem (2005) 1.06
Cellular uptake of Antennapedia Penetratin peptides is a two-step process in which phase transfer precedes a tryptophan-dependent translocation. Nucleic Acids Res (2003) 1.04
Regulation of the endogenous VEGF-A gene by exogenous designed regulatory proteins. Proc Natl Acad Sci U S A (2004) 1.04
Penetratin-membrane association: W48/R52/W56 shield the peptide from the aqueous phase. Biophys J (2004) 1.04
Enhanced cell-permeant Cre protein for site-specific recombination in cultured cells. BMC Biotechnol (2004) 1.04
Asymmetric insertion of membrane proteins in lipid bilayers by solid-state NMR paramagnetic relaxation enhancement: a cell-penetrating Peptide example. J Am Chem Soc (2008) 1.03
Prediction of cell penetrating peptides by support vector machines. PLoS Comput Biol (2011) 1.03
The C-terminal transmembrane domain of hepatitis C virus (HCV) RNA polymerase is essential for HCV replication in vivo. J Virol (2004) 1.03
Comparative study on transduction and toxicity of protein transduction domains. Br J Pharmacol (2008) 1.02
Cell penetrating elastin-like polypeptides for therapeutic peptide delivery. Adv Drug Deliv Rev (2010) 1.02
Cell penetrating peptides: how do they do it? J Biol Phys (2008) 1.01
Disruption of SLP-76 interaction with Gads inhibits dynamic clustering of SLP-76 and FcepsilonRI signaling in mast cells. Mol Cell Biol (2006) 1.01
Targeted gene modification of hematopoietic progenitor cells in mice following systemic administration of a PNA-peptide conjugate. Mol Ther (2011) 1.01
Targeting antiapoptotic Bcl-2 family members with cell-permeable BH3 peptides induces apoptosis signaling and death in head and neck squamous cell carcinoma cells. Neoplasia (2007) 1.00
Maurocalcine as a non toxic drug carrier overcomes doxorubicin resistance in the cancer cell line MDA-MB 231. Pharm Res (2008) 0.99
Mechanism and regulatory function of CpG signaling via scavenger receptor B1 in primary B cells. J Biol Chem (2009) 0.98
Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotides. Nucleic Acids Res (2004) 0.98
Fusion of HIV-1 Tat protein transduction domain to poly-lysine as a new DNA delivery tool. Br J Cancer (2004) 0.98
A novel cell-penetrating peptide derived from human eosinophil cationic protein. PLoS One (2013) 0.97
Lipid binding activities of flax rust AvrM and AvrL567 effectors. Plant Signal Behav (2010) 0.97
Membrane-mediated peptide conformation change from alpha-monomers to beta-aggregates. Biophys J (2010) 0.97
Dominant-negative regulation of cell surface expression by a pentapeptide motif at the extreme COOH terminus of an Slo1 calcium-activated potassium channel splice variant. Mol Pharmacol (2010) 0.97
Mechanism of peptide-induced mast cell degranulation. Translocation and patch-clamp studies. J Gen Physiol (1998) 0.97
Facilitating oligonucleotide delivery: helping antisense deliver on its promise. Proc Natl Acad Sci U S A (1996) 0.97
Cell-penetrating peptide (CPP)-conjugated proteins is an efficient tool for manipulation of human mesenchymal stromal cells. Sci Rep (2014) 0.96
Coordinate regulation of cadherin and integrin function by the chondroitin sulfate proteoglycan neurocan. J Cell Biol (2000) 0.96
A critical reassessment of penetratin translocation across lipid membranes. Biophys J (2005) 0.96
Proteins in unexpected locations. Mol Biol Cell (1996) 0.96
In vivo imaging with a cell-permeable porphyrin-based MRI contrast agent. Chem Biol (2010) 0.96
Polyreactive anti-DNA monoclonal antibodies and a derived peptide as vectors for the intracytoplasmic and intranuclear translocation of macromolecules. Proc Natl Acad Sci U S A (1998) 0.95
Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotides. Nucleic Acids Res (2000) 0.95
Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA. Mol Ther Nucleic Acids (2012) 0.95
Cell penetrating peptide inhibitors of nuclear factor-kappa B. Cell Mol Life Sci (2008) 0.95
A peptide-based vector for efficient gene transfer in vitro and in vivo. Mol Ther (2011) 0.95
On the mechanisms of the internalization of S4(13)-PV cell-penetrating peptide. Biochem J (2005) 0.94
Designing mimics of membrane active proteins. Acc Chem Res (2013) 0.93
Magnesium gates glutamate-activated channels in mouse central neurones. Nature (1984) 13.67
Studies on the sequence of the 3'-terminal region of turnip-yellow-mosaic-virus RNA. Eur J Biochem (1977) 4.95
Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem (1996) 3.18
Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol (1998) 2.89
Cell-penetrating peptides. Trends Pharmacol Sci (2000) 2.42
Antennapedia homeobox peptide regulates neural morphogenesis. Proc Natl Acad Sci U S A (1991) 2.31
SET protein (TAF1beta, I2PP2A) is involved in neuronal apoptosis induced by an amyloid precursor protein cytoplasmic subdomain. FASEB J (2005) 1.41
A common exocytotic mechanism mediates axonal and dendritic outgrowth. J Neurosci (2001) 1.31
Axonal amyloid precursor protein expressed by neurons in vitro is present in a membrane fraction with caveolae-like properties. J Biol Chem (1996) 1.29
Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro. J Cell Biol (1995) 1.28
J1/tenascin in substrate-bound and soluble form displays contrary effects on neurite outgrowth. J Cell Biol (1991) 1.27
Downregulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxynitrite pathway. J Neurosci (1996) 1.24
Identification of a signal sequence necessary for the unconventional secretion of Engrailed homeoprotein. Curr Biol (1998) 1.22
Possible existence of a new tachykinin receptor subtype in the guinea pig ileum. Peptides (1992) 1.21
A short cytoplasmic domain of the amyloid precursor protein induces apoptosis in vitro and in vivo. Mol Cell Neurosci (2001) 1.20
Antennapedia homeobox as a signal for the cellular internalization and nuclear addressing of a small exogenous peptide. J Cell Sci (1992) 1.20
Glial heterogeneity may define the three-dimensional shape of mouse mesencephalic dopaminergic neurones. Nature (1984) 1.20
A short region of its homeodomain is necessary for engrailed nuclear export and secretion. Development (1999) 1.19
alpha-2,8-Polysialic acid is the neuronal surface receptor of antennapedia homeobox peptide. New Biol (1991) 1.19
The contrasting roles of ICE family proteases and interleukin-1beta in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation. Proc Natl Acad Sci U S A (1996) 1.16
Intraneuronal delivery of protein kinase C pseudosubstrate leads to growth cone collapse. J Neurosci (1995) 1.16
Conformational and associative behaviours of the third helix of antennapedia homeodomain in membrane-mimetic environments. Eur J Biochem (1996) 1.11
Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurones grown in serum-free conditions. Nature (1980) 1.09
Evidence that axon-derived neuregulin promotes oligodendrocyte survival in the developing rat optic nerve. Neuron (2000) 1.09
The product of rab2, a small GTP binding protein, increases neuronal adhesion, and neurite growth in vitro. Neuron (1990) 1.08
In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells. Proc Natl Acad Sci U S A (1979) 1.05
Brain macrophages synthesize interleukin-1 and interleukin-1 mRNAs in vitro. J Neurosci Res (1989) 1.04
Inhibition of FGF-stimulated phosphatidylinositol hydrolysis and neurite outgrowth by a cell-membrane permeable phosphopeptide. Curr Biol (1996) 1.04
Penetratin-membrane association: W48/R52/W56 shield the peptide from the aqueous phase. Biophys J (2004) 1.04
Microheterogeneity of tubulin proteins in neuronal and glial cells from the mouse brain in culture. EMBO J (1983) 1.02
Survival and function of dissociated rat dopamine neurones grafted at different developmental stages or after being cultured in vitro. Brain Res (1988) 1.01
In vitro control of neuronal polarity by glycosaminoglycans. Development (1992) 0.99
Neurotrophic activity of the Antennapedia homeodomain depends on its specific DNA-binding properties. Proc Natl Acad Sci U S A (1993) 0.99
Lipopolysaccharide-stimulated rat brain macrophages release NGF in vitro. Dev Biol (1989) 0.97
[3H]neurokinin B and 125I-Bolton Hunter eledoisin label identical tachykinin binding sites in the rat brain. J Neurochem (1987) 0.97
Specific responses of axons and dendrites to cytoskeleton perturbations: an in vitro study. J Cell Sci (1993) 0.96
Avidin binding of biotinylated analogues of substance P. Biochim Biophys Acta (1983) 0.95
Preferential conformation of substance P in solution. Eur J Biochem (1986) 0.94
Amyloid precursor protein cytoplasmic domain antagonizes reelin neurite outgrowth inhibition of hippocampal neurons. Neurobiol Aging (2006) 0.93
Analysis of tachykinin binding site interactions using constrained analogues of tachykinins. Biochem Pharmacol (1988) 0.93
Developmental and regional regulation of rab3: a new brain specific "ras-like" gene. J Neurosci Res (1989) 0.93
The amyloid precursor protein interacts with Go heterotrimeric protein within a cell compartment specialized in signal transduction. J Neurosci (1999) 0.92
Modulation of interleukin-1 and tumor necrosis factor expression by beta-adrenergic agonists in mouse ameboid microglial cells. Exp Brain Res (1991) 0.92
3H-neurokinin A labels a specific tachykinin-binding site in the rat duodenal smooth muscle. Mol Pharmacol (1987) 0.92
Association of Engrailed homeoproteins with vesicles presenting caveolae-like properties. Development (1997) 0.92
Neuromedin K, a tool to further distinguish two central tachykinin binding sites. Eur J Pharmacol (1984) 0.91
Influence of extracellular matrix proteins on the expression of neuronal polarity. Development (1989) 0.91
Rat mesencephalic neurons in culture exhibit different morphological traits in the presence of media conditioned on mesencephalic or striatal astroglia. Dev Biol (1988) 0.91
Characterization of non-peptide antagonist and peptide agonist binding sites of the NK1 receptor with fluorescent ligands. J Biol Chem (1997) 0.91
TYMV RNA as a substrate of tRNA maturation endonuclease. Nat New Biol (1973) 0.91
Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors. J Pharmacol Exp Ther (1996) 0.91
MAP2 expression and neuritic outgrowth and branching are coregulated through region-specific neuro-astroglial interactions. J Neurosci (1987) 0.90
Inhibition of brain adenylate cyclase by A1 adenosine receptors: pharmacological characteristics and locations. Brain Res (1983) 0.90
The neuronal microtubule-associated protein 1B is under homeoprotein transcriptional control. J Neurosci (2001) 0.89
Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo. J Immunol (1996) 0.88
Antennapedia homeobox peptide enhances growth and branching of embryonic chicken motoneurons in vitro. J Cell Biol (1993) 0.88
Specific stimulation of in vitro maturation of mesencephalic dopaminergic neurones by striatal membranes. Nature (1981) 0.87
Transcription factor hoxa-5 is taken up by cells in culture and conveyed to their nuclei. Mech Dev (1996) 0.86
Specific binding of an immunoreactive and biologically active 125I-labeled substance P derivative to mouse mesencephalic cells in primary culture. Mol Pharmacol (1982) 0.86
Binding of substance P to monolayers and vesicles made of phosphatidylcholine and/or phosphatidylserine. Biochim Biophys Acta (1992) 0.86
Rab3A and Rab3B carboxy-terminal peptides are both potent and specific inhibitors of prolactin release by rat cultured anterior pituitary cells. Mol Endocrinol (1994) 0.86
Post mortem stability and storage in the cold of brain enzymes. J Neurochem (1979) 0.85
Influence of the replacement of amino acid by its D-enantiomer in the sequence of substance P. 2. Conformational analysis by NMR and energy calculations. Neuropeptides (1991) 0.85
TYMV valyl-RNA as an amino-acid donor in protein biosynthesis. Nat New Biol (1973) 0.85
Specific recognition of SP or NKB receptors by analogues of SP substituted at positions 8 and 9. Eur J Pharmacol (1986) 0.84
Brain astrocytes express region-specific surface glycoproteins in culture. Glia (1988) 0.84
Further delineation of the two binding sites (R*(n)) associated with tachykinin neurokinin-1 receptors using [3-Prolinomethionine(11)]SP analogues. J Biol Chem (1999) 0.84
Long-term development of mesencephalic dopaminergic neurons of mouse embryos in dissociated primary cultures: morphological and histochemical characteristics. Neuroscience (1982) 0.84
Developmental and regional expression of three new members of the ras-gene family in the mouse brain. J Neurosci Res (1989) 0.84
Specific influence of striatal target neurons on the in vitro outgrowth of mesencephalic dopaminergic neurites: a morphological quantitative study. J Neurosci (1983) 0.83
Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with Parkinson's disease. Ann N Y Acad Sci (1987) 0.83
Coupling of MALDI-TOF mass analysis to the separation of biotinylated peptides by magnetic streptavidin beads. Anal Chem (1996) 0.83
Intermediate filament proteins in mouse brain cells cultured in the presence or absence of fetal calf serum. Exp Cell Res (1982) 0.83
In vitro regulation of neuronal morphogenesis and polarity by astrocyte-derived factors. Dev Biol (1990) 0.83
Two simian virus 40 (SV40)-transformed cell lines from the mouse striatum and mesencephalon presenting astrocytic characters. II. Interactions with mesencephalic neurons. Brain Res (1986) 0.82
The rotating 6-hydroxydopamine-lesioned mouse as a model for assessing functional effects of neuronal grafting. Brain Res (1986) 0.82
A cyclic analogue selective for the NKB specific binding site on rat brain synaptosomes. Eur J Pharmacol (1986) 0.82
In vitro studies on the maturation of mesencephalic dopaminergic neurons. Dev Neurosci (1985) 0.82
Further demonstration that [Pro9]-substance P is a potent and selective ligand of NK-1 tachykinin receptors. J Neurochem (1991) 0.81
Promoter-specific regulation of gene expression by an exogenously added homedomain that promotes neurite growth. FEBS Lett (1995) 0.81
Amyloid precursor protein in cortical neurons: coexistence of two pools differentially distributed in axons and dendrites and association with cytoskeleton. J Neurosci (1994) 0.81
Biogenic amines and adenosine-sensitive adenylate cyclases in primary cultures of striatal neurons. Brain Res (1983) 0.81
Two simian virus 40 (SV40)-transformed cell lines from the mouse striatum and mesencephalon presenting astrocytic characters. I. Immunological and pharmacological properties. Brain Res (1986) 0.81
The use of photolabelled peptides to localize the substance-P-binding site in the human neurokinin-1 tachykinin receptor. Eur J Biochem (1996) 0.80
Modeling homeoprotein intercellular transfer unveils a parsimonious mechanism for gradient and boundary formation in early brain development. J Theor Biol (2007) 0.80
An induction gene trap for identifying a homeoprotein-regulated locus. Nat Biotechnol (2000) 0.80
Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2 and NK3 tachykinin receptors. Regul Pept (1993) 0.80
High affinity binding of [3H]propionyl-[Met(O2)11]substance P(7-11), a tritiated septide-like peptide, in Chinese hamster ovary cells expressing human neurokinin-1 receptors and in rat submandibular glands. Mol Pharmacol (1997) 0.80
Secretion of nerve growth factor in cultures of glial cells and neurons derived from different regions of the mouse brain. J Neurosci Res (1989) 0.79
Peptide nucleic acid smugglers. Nat Biotechnol (1998) 0.79
Analogs of Substance P modified at the C-terminus which are both agonist and antagonist of the NK-1 receptor depending on the second messenger pathway. J Pept Res (2002) 0.79
Defined glycosaminoglycan motifs have opposite effects on neuronal polarity in vitro. Dev Biol (1994) 0.79
Properties of substance P aggregates. Application to the synthesis and purification of substance P. Biochem Biophys Res Commun (1983) 0.79